专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2004026316A1 NOVEL USE OF CARBOHYDRATES AND COMPOSITIONS 审中-公开
标题翻译：碳水化合物和组合物的新用途
公开(公告)号：WO2004026316A1
公开(公告)日：2004-04-01
申请号：PCT/FI2003/000674
申请日：2003-09-16
申请人： DANISCO A/S , RAUTONEN, Nina , APAJALAHTI, Juha , KETTUNEN, Anu , SIIKANEN, Osmo
发明人： RAUTONEN, Nina , APAJALAHTI, Juha , KETTUNEN, Anu , SIIKANEN, Osmo
IPC分类号： A61K31/70
CPC分类号： A61K31/70 , A23C9/133 , A23C9/137 , A23G1/56 , A23G2200/06 , A23L13/426 , A23L33/10 , A23L33/135 , A23V2002/00 , A23V2250/206 , A23V2250/5026 , A23V2250/5072 , A23V2250/6414
摘要： The present invention relates to the use of carbohydrates in the preparation of a composition for treating and/or preventing diseases and/or disorders caused by imbalanced fermentation in the colon comprising providing composition capable of maintaining a sustained and controlled fermentation throughout the colon of a subject by formulating slowly fermented complex oligomeric or polymeric carbohydrate(s) into a nutritionally, nutraceutically and/or pharmacologically acceptable composition. The present invention also relates to a composition comprising a slowly fermented complex oligomer or polymer carbohydrate as an active component for sustaining and controlling the fermentation throughout the colon of a subject.
摘要翻译：本发明涉及碳水化合物在制备用于治疗和/或预防由结肠不平衡发酵引起的疾病和/或障碍的组合物中的用途，其包括提供能够维持受试者整个结肠持续和控制发酵的组合物通过将缓慢发酵的复合寡聚或聚合碳水化合物配制成营养，营养和/或药学上可接受的组合物。本发明还涉及一种组合物，其包含缓慢发酵的复合低聚物或聚合物碳水化合物作为用于维持和控制受试者整个结肠发酵的活性成分。

2. 发明申请

WO2003059333A2 STIMULATION OF THE IMMUNE SYSTEM WITH POLYDEXTROSE 审中-公开
标题翻译：用聚葡萄糖刺激免疫系统
公开(公告)号：WO2003059333A2
公开(公告)日：2003-07-24
申请号：PCT/EP2002/014719
申请日：2002-12-23
申请人： DANISCO A/S
发明人： RAUTONEN, Nina , APAJALAHTI, Juha , TIIHONEN, Kirsti
IPC分类号： A61K31/00
CPC分类号： A23L33/26
摘要： The invention relates to the use of polydextrose for stimulating the immune response (IgA) in the gastrointestinal tract of a mammal. Furthermore, the invention provides a method to potentiate the immunostimulative effect of polydextrose by mixing at least one polyol with polydextrose, said polyol being effective to synergistically increase the immunoglobulin A (IgA) concentration in the gut of a mammal. On the other hand, the invention provides also compositions containing polydextrose and polyols in which the laxative effects of polyols are reduced and which are effective to reduce the amount of biogenic amines in the gut of a mammal.
摘要翻译：本发明涉及聚葡萄糖用于刺激哺乳动物的胃肠道中的免疫应答（IgA）的用途。此外，本发明提供了一种通过混合至少一种多元醇与聚右旋糖来增强聚右旋糖的免疫刺激作用的方法，所述多醇有效地协同增加哺乳动物肠道中的免疫球蛋白A（IgA）浓度。另一方面，本发明还提供了含有聚葡萄糖和多元醇的组合物，其中多元醇的缓泻作用降低，并且能有效地减少哺乳动物肠道中生物胺的量。

3. 发明公开

EP1667697A2 METHOD TO TREAT THE SIDE EFFECTS ASSOCIATED WITH NON STEROIDAL ANTI-INFLAMMATORY DRUGS USING MICROORGANISMS OF THE GENUS BIFIDOBACTERIUM. 审中-公开
标题翻译：方法的副作用有和使用双歧杆菌属微生物非甾体抗炎药的治疗。
公开(公告)号：EP1667697A2
公开(公告)日：2006-06-14
申请号：EP04787556.2
申请日：2004-09-24
申请人： DANISCO A/S
发明人： RAUTONEN, Nina , NURMI, Jussi , NURMINEN, Päivi , PUOLAKKAINEN, Pauli
IPC分类号： A61K35/74 , A61K31/19 , A61K31/205 , A61P29/00
CPC分类号： A61K35/745 , A23K10/16 , A23K10/18 , A23K50/75 , A61K31/19 , A61K31/205 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the use of a microorganism and/or a metabolite thereof to at least increase the amount of a COX-1 mRNA in a cell. The present invention further relates to the use of a microorganism and/or a metabolite thereof in the manufacture of a medicament to treat the side effects associated with nonsteroidal antiinflammatory drugs (NSAIDs). The present invention further relates to a pharmaceutical preparation comprising in combination a nonsteroidal antiinflammatory drug (NSAIDs) and a microorganism and/or a metabolite thereof which is capable of at least increasing the amount of a COX-1 mRNA in a cell. The present invention yet further relates to a pharmaceutical preparation comprising in combination betaine or a pharmaceutically acceptable salt thereof and a microorganism and/or a metabolite thereof which is capable of at least increasing the amount of a COX-1 mRNA in a cell. The microorganism may suitably be a bacterium, preferably from the genus Bifidobacterium.

4. 发明申请

WO2007085970A2 USE 审中-公开
标题翻译：使用
公开(公告)号：WO2007085970A2
公开(公告)日：2007-08-02
申请号：PCT/IB2007/001186
申请日：2007-01-26
申请人： DANISCO A/S , RAUTONEN, Nina , PUTAALA, Heli , OUWEHAND, Arthur , TIIHONEN, Kirsti
发明人： RAUTONEN, Nina , PUTAALA, Heli , OUWEHAND, Arthur , TIIHONEN, Kirsti
IPC分类号： A61K35/745 , A61K35/747
CPC分类号： A61K35/747 , A23K10/18 , A23K50/40 , A23K50/75 , A23L33/135 , A23L33/30 , A61K35/745
摘要： Use of at least one strain of a microorganism and/or a metabolite thereof in the manufacture of a support for administration to a subject for modulating satiety signalling, wherein the support is a pharmaceutically acceptable support or a food product. Suitably, the at least one strain of a microorganism and/or a metabolite thereof may be administered to the subject for the treatment and/or prevention of excess weight and/or a disease caused by excess weight. Likewise, the at least one strain of a microorganism and/or a metabolite thereof is administered to the subject for the treatment and/or prevention of obesity and/or a disease caused by obesity. Preferably, the microorganism is a probiotic microorganism. Suitably the microorganism may be a lactic acid bacterium. Li one embodiment the microorganism is a strain of Lactobacillus spp. and/or Bifidobacterium spp., for example a strain of Lactobacillus acidophilus, L. curvatus, L. salivarius and/or B. lactis.
摘要翻译：至少一种微生物菌株和/或其代谢物在制备用于施用受试者以调节饱腹感信号的载体中的用途，其中所述载体是药学上可接受的载体或食品。适当地，将微生物和/或其代谢物的至少一种菌株施用于受试者以治疗和/或预防超重和/或由超重引起的疾病。同样地，向受试者施用至少一种微生物和/或其代谢物，用于治疗和/或预防肥胖症和/或由肥胖引起的疾病。优选地，微生物是益生菌微生物。适当地，微生物可以是乳酸菌。李一个实例是微生物是一种乳杆菌属菌株。和/或双歧杆菌属，例如嗜酸乳杆菌，弯曲曲霉，唾液乳杆菌和/或乳酸乳杆菌的菌株。

5. 发明申请

WO2005032567A2 METHOD 审中-公开
标题翻译：方法
公开(公告)号：WO2005032567A2
公开(公告)日：2005-04-14
申请号：PCT/IB2004/003273
申请日：2004-09-24
申请人： DANISCO A/S , RAUTONEN, Nina , NURMI, Jussi , NURMINEN, Päivi , PUOLAKKAINEN, Pauli
发明人： RAUTONEN, Nina , NURMI, Jussi , NURMINEN, Päivi , PUOLAKKAINEN, Pauli
IPC分类号： A61K35/74
CPC分类号： A61K35/745 , A23K10/16 , A23K10/18 , A23K50/75 , A61K31/19 , A61K31/205 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the use of a microorganism and/or a metabolite thereof to at least increase the amount of a COX-1 mRNA in a cell. The present invention further relates to the use of a microorganism and/or a metabolite thereof in the manufacture of a medicament to treat the side effects associated with nonsteroidal antiinflammatory drugs (NSAIDs). The present invention further relates to a pharmaceutical preparation comprising in combination a nonsteroidal antiinflammatory drug (NSAIDs) and a microorganism and/or a metabolite thereof which is capable of at least increasing the amount of a COX-1 mRNA in a cell. The present invention yet further relates to a pharmaceutical preparation comprising in combination betaine or a pharmaceutically acceptable salt thereof and a microorganism and/or a metabolite thereof which is capable of at least increasing the amount of a COX-1 mRNA in a cell. The microorganism may suitably be a bacterium, preferably from the genus Bifidobacterium.
摘要翻译：本发明涉及使微生物和/或其代谢物至少增加细胞中COX-1mRNA的量的用途。本发明还涉及微生物和/或其代谢物在制备用于治疗与非甾体抗炎药（NSAID）相关的副作用的药物中的用途。本发明还涉及一种药物制剂，其包含非甾体抗炎药（NSAID）和能够至少增加细胞中COX-1mRNA量的微生物和/或其代谢物的组合。本发明还涉及包含组合甜菜碱或其药学上可接受的盐和能够至少增加细胞中COX-1 mRNA的量的微生物和/或其代谢物的药物制剂。微生物可以适当地是细菌，优选来自双歧杆菌属。

6. 发明申请

WO2003059333A3 STIMULATION OF THE IMMUNE SYSTEM WITH POLYDEXTROSE 审中-公开
公开(公告)号：WO2003059333A3
公开(公告)日：2003-07-24
申请号：PCT/EP2002/014719
申请日：2002-12-23
申请人： DANISCO A/S
发明人： RAUTONEN, Nina , APAJALAHTI, Juha , TIIHONEN, Kirsti
IPC分类号： A23L1/308
摘要： The invention relates to the use of polydextrose for stimulating the immune response (IgA) in the gastrointestinal tract of a mammal. Furthermore, the invention provides a method to potentiate the immunostimulative effect of polydextrose by mixing at least one polyol with polydextrose, said polyol being effective to synergistically increase the immunoglobulin A (IgA) concentration in the gut of a mammal. On the other hand, the invention provides also compositions containing polydextrose and polyols in which the laxative effects of polyols are reduced and which are effective to reduce the amount of biogenic amines in the gut of a mammal.

7. 发明公开

EP2091340A1 COMPOSITION 无效转让
标题翻译：组成
公开(公告)号：EP2091340A1
公开(公告)日：2009-08-26
申请号：EP07848462.3
申请日：2007-12-10
申请人： Danisco A/S
发明人： RAUTONEN, Nina , OUWEHAND, Arthur , STOWELL, Julian , MAKELAINEN, Henna
IPC分类号： A23C9/123 , A23C9/13 , A23C9/152 , A23L1/00 , A23L1/29 , A23L1/30 , A23L2/39
CPC分类号： A23C9/1234 , A23C9/1307 , A23C9/152 , A23L2/39 , A23L33/135 , A23L33/21 , A23L33/40 , A23V2002/00 , A23Y2300/00 , A23V2250/28 , A23V2200/08
摘要： The present invention provides a composition comprising: (a) one or more live Bifidobacterium lactis strains; and (b) a saccharide component; wherein the saccharide component comprises xylo-oligosaccharides with a degree of polymerisation of from 2 to 100.
摘要翻译：本发明提供了一种组合物，其包含：（a）一种或多种活乳双歧杆菌菌株; 和（b）糖类组分; 其中所述糖组分包含聚合度为2至100的低聚木糖。

8. 发明公开

EP1465505A2 STIMULATION OF THE IMMUNE SYSTEM WITH POLYDEXTROSE 失效转让
标题翻译：起搏POLYDEXTROSE免疫系统
公开(公告)号：EP1465505A2
公开(公告)日：2004-10-13
申请号：EP02799071.2
申请日：2002-12-23
申请人： DANISCO A/S
发明人： RAUTONEN, Nina , APAJALAHTI, Juha , TIIHONEN, Kirsti
IPC分类号： A23L1/308
CPC分类号： A23L33/26
摘要： The invention relates to the use of polydextrose for stimulating the immune response (IgA) in the gastrointestinal tract of a mammal. Furthermore, the invention provides a method to potentiate the immunostimulative effect of polydextrose by mixing at least one polyol with polydextrose, said polyol being effective to synergistically increase the immunoglobulin A (IgA) concentration in the gut of a mammal. On the other hand, the invention provides also compositions containing polydextrose and polyols in which the laxative effects of polyols are reduced and which are effective to reduce the amount of biogenic amines in the gut of a mammal.

9. 发明申请

WO2011013106A1 LACTIC ACID BACTERIA AND BIFIDOBACTERIA FOR TREATING ENDOTOXEMIA 审中-公开
标题翻译：用于治疗内毒素的乳酸菌和双歧杆菌
公开(公告)号：WO2011013106A1
公开(公告)日：2011-02-03
申请号：PCT/IB2010/053482
申请日：2010-07-30
申请人： DANISCO A/S , BURCELIN, Rémy , CARCANO, Didier , DESREUMAUX, Pierre , LAHTINEN, Sampo , RAUTONEN, Nina , PUTAALA, Heli , TIIHONEN, Kirsti , BARRANGOU, Rodolphe
发明人： BURCELIN, Rémy , CARCANO, Didier , DESREUMAUX, Pierre , LAHTINEN, Sampo , RAUTONEN, Nina , PUTAALA, Heli , TIIHONEN, Kirsti , BARRANGOU, Rodolphe
IPC分类号： A61K35/74 , A61P5/50 , A61P29/00
CPC分类号： A61K35/747 , A61K35/74 , A61K35/745 , A61K2035/115 , A61P5/50 , A61P29/00 , A61K2300/00
摘要： The invention relates to use of a bacterium selected from a lactic acid bacterium, a Bifidobacterium or a mixture of any thereof for treating metabolic endotoxemia, inhibiting bacterial translocation and regulating lipid absorption in a mammal.
摘要翻译：本发明涉及选自乳酸菌，双歧杆菌或其混合物中的细菌用于治疗代谢性内毒素血症，抑制细菌易位并调节哺乳动物脂质吸收的用途。

10. 发明申请

WO2004002240A2 NOVEL USE AND COMPOSITIONS 审中-公开
标题翻译：新的使用和组成
公开(公告)号：WO2004002240A2
公开(公告)日：2004-01-08
申请号：PCT/IB2003/003282
申请日：2003-06-20
申请人： DANISCO A/S , RAUTONEN, Nina , APAJALAHTI, Juha , SIIKANEN, Osmo
发明人： RAUTONEN, Nina , APAJALAHTI, Juha , SIIKANEN, Osmo
IPC分类号： A23L1/00
CPC分类号： A23L29/27 , A23L29/256 , A23V2002/00 , A23V2250/5086 , A23V2250/5072 , A23V2250/507 , A23V2250/5062 , A23V2250/5026
摘要： The use of a hydrocolloid as a prebiotic in the preparation of a product for consumption is described. The hydrocolloid has the advantage of reduced gas release when fermented by bacteria in the gastrointestinal tract after the consumption of said product. Compositions containing the hydrocolloid, methods for using the compositions in methods of treatment are also provided.
摘要翻译：描述了在制备用于消费的产品中使用水胶体作为益生元。水胶体具有在消耗所述产品之后在胃肠道中被细菌发酵时减少气体释放的优点。还提供了含有水胶体的组合物，在治疗方法中使用该组合物的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式